| abstract |
The present invention relates to the use of certain [1,3] dioxanes to enhance the effect of GABA on GABA A receptors. It further relates to medicaments or pharmaceutical compositions containing one or more of these [1,3] -dioxanes, which are particularly suitable for the treatment of depression, restlessness and anxiety, sleep disorders, epilepsy, dementia, alcoholism and / or migraine. Finally, special, previously unknown [1,3] dioxanes and a process for their preparation are provided. |